UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Mendel Money Management

Mendel Money Management grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,211 shares of the healthcare conglomerate’s stock after acquiring an additional 131 shares during the quarter. Mendel Money Management’s holdings in UnitedHealth Group were worth $1,624,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Parametrica Management Ltd acquired a new stake in UnitedHealth Group in the fourth quarter worth $393,000. Ausdal Financial Partners Inc. grew its position in UnitedHealth Group by 8.3% in the 4th quarter. Ausdal Financial Partners Inc. now owns 1,756 shares of the healthcare conglomerate’s stock worth $888,000 after purchasing an additional 134 shares during the last quarter. TrueMark Investments LLC boosted its position in shares of UnitedHealth Group by 54.1% during the fourth quarter. TrueMark Investments LLC now owns 10,260 shares of the healthcare conglomerate’s stock worth $5,190,000 after buying an additional 3,602 shares during the period. Financial Engines Advisors L.L.C. grew its stake in shares of UnitedHealth Group by 59.3% in the fourth quarter. Financial Engines Advisors L.L.C. now owns 3,835 shares of the healthcare conglomerate’s stock worth $1,940,000 after purchasing an additional 1,428 shares in the last quarter. Finally, Penobscot Investment Management Company Inc. lifted its holdings in UnitedHealth Group by 0.9% in the fourth quarter. Penobscot Investment Management Company Inc. now owns 28,512 shares of the healthcare conglomerate’s stock worth $14,423,000 after purchasing an additional 252 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE:UNH opened at $513.58 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company’s 50-day moving average price is $509.10 and its two-hundred day moving average price is $545.56. The stock has a market capitalization of $469.78 billion, a PE ratio of 33.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.